The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 2×
“Specifically, IL-6 induces the generation of Th17 cells together with TGF-beta [12–15], while”
BackgroundChen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 1×
“Specifically, IL-6 induces the generation of Th17 cells together with TGF-beta [12–15], while”
BackgroundTransforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“Specifically, IL-6 induces the generation of Th17 cells together with TGF-beta [12–15], while”
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 1×
“Interleukin-6 (IL-6) was discovered in 1986 by Hirano and Kishimoto as a B cell stimulatory factor driving IgG production [1].”
BackgroundIL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Self-citationEmery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Bollrath, J., Phesse, T. J., von Burstin, V. A., Putoczki, T., Bennecke, M., Bateman, T., Nebelsiek, T., Lundgren-May, T., Canli, Ö., Schwitalla, S., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.002 · Cited by 946
Kiesslich, R., Fritsch, J., Holtmann, M., Koehler, H. H., Stolte, M., Kanzler, S., Nafe, B., Jung, M., Galle, P. R., & Neurath, M. F. (2003) · Gastroenterology · doi:10.1053/gast.2003.50146 · Cited by 861
Self-citationIL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846 · cited 1×
“inflammatory activity upon blockade of the IL-6R using a neutralizing monoclonal antibody [109].”
MethodHurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationNeufert, C., Becker, C., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.279 · Cited by 675
Self-citationIto, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
The role of Th1/Th2 polarization in mucosal immunity
Neurath, M. F., Finotto, S., & Glimcher, L. H. (2002) · Nature Medicine · doi:10.1038/nm0602-567 · Cited by 623
Self-citationAn update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus
Rabinovitch, A. (1998) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199806)14:2<129::aid-dmr208>3.0.co;2-v · Cited by 461
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Self-citationSamoilova, E. B., Horton, J. L., Hilliard, B., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 440
Wong, C. K., Ho, C. Y., Ko, F. W. S., Chan, C. H. S., Ho, A. S. S., Hui, D. S. C., & Lam, C. W. K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01602.x · Cited by 440
Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance
Mudter, J., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20148 · Cited by 436
Self-citationIL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411 · cited 2×
“and VCAM-1 and proinflammatory cytokine levels (IFN-gamma, TNF-alpha, and IL-1beta) were reduced by anti-IL-6R antibody treatment [89].”
BackgroundIL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3
Fielding, C. A., McLoughlin, R. M., McLeod, L., Colmont, C. S., Najdovska, M., Grail, D., Ernst, M., Jones, S. A., Topley, N., & Jenkins, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2189 · Cited by 408
Lagathu, C., Bastard, J.-P., Auclair, M., Maachi, M., Capeau, J., & Caron, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.013 · Cited by 385
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 349
Hashizume, M., Hayakawa, N., & Mihara, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken363 · Cited by 347
Li, Y., de Haar, C., Chen, M., Deuring, J., Gerrits, M. M., Smits, R., Xia, B., Kuipers, E. J., & van der Woude, C. J. (2010) · Gut · doi:10.1136/gut.2009.184176 · Cited by 339 · cited 2×
“development of inflammation-associated colon cancer in UC [98].”
BackgroundIL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Self-citationDoganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Self-citationNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
IL-6 rescues resting mouse T cells from apoptosis
Teague, T. K., Marrack, P., Kappler, J. W., & Vella, A. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5791 · Cited by 248
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Okuda, Y. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 229
Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 227
Self-citationFujimoto, M., Serada, S., Mihara, M., Uchiyama, Y., Yoshida, H., Koike, N., Ohsugi, Y., Nishikawa, T., Ripley, B., Kimura, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24126 · Cited by 225
Signal transduction pathways and transcriptional regulation in Th17 cell differentiation
Hirahara, K., Ghoreschi, K., Laurence, A., Yang, X.-P., Kanno, Y., & O'Shea, J. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.006 · Cited by 219
Nowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Matsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
DiCosmo, B. F., Geba, G. P., Picarella, D., Elias, J. A., Rankin, J. A., Stripp, B. R., Whitsett, J. A., & Flavell, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117556 · Cited by 208
Jones, G. W., McLoughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., Scheller, J., Williams, A. S., Rose-John, S., Topley, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901528 · Cited by 189
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Hokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 171
VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
Waldner, M. J., Wirtz, S., Jefremow, A., Warntjen, M., Neufert, C., Atreya, R., Becker, C., Weigmann, B., Vieth, M., Rose-John, S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100438 · Cited by 170
Self-citationRoles of IL-6-gp130 Signaling in Vascular Inflammation
Hou, T., Tieu, B. C., Ray, S., Recinos, A., Cui, R., Tilton, R. G., & Brasier, A. R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160570 · Cited by 167
IL-6 detection in multiple sclerosis brain
Maimone, D., Guazzi, G. C., & Annunziata, P. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00283-3 · Cited by 165
Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice
Mendel, I., Katz, A., Kozak, N., Ben‐Nun, A., & Revel, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1727::aid-immu1727>3.0.co;2-# · Cited by 162
Fujimoto, M., Nakano, M., Terabe, F., Kawahata, H., Ohkawara, T., Han, Y., Ripley, B., Serada, S., Nishikawa, T., Kimura, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903314 · Cited by 160
Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice
Hulbert, C., Riseili, B., Rojas, M., & Thomas, J. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5535 · Cited by 153
Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Hyams, J. S., Fitzgerald, J. E., Treem, W. R., Wyzga, N., & Kreutzer, D. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90336-b · Cited by 146
Patanella, A. K., Zinno, M., Quaranta, D., Nociti, V., Frisullo, G., Gainotti, G., Tonali, P., Batocchi, A. P., & Marra, C. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22276 · Cited by 144
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 143
Self-citationPathological Role of IL-6 in the Experimental Allergic Bronchial Asthma in Mice
Doganci, A., Sauer, K., Karwot, R., & Finotto, S. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:257 · Cited by 142
Self-citationInterleukin-6 trans-signaling in inflammatory bowel disease
Mitsuyama, K., Sata, M., & Rose‐John, S. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.003 · Cited by 139
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Mudter, J., & Neurath, M. F. (2006) · Gut · doi:10.1136/gut.2005.090464 · Cited by 139
Self-citationlnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases
Swaak, A. J. G., Rooyen, A. V., Nieuwenhuis, E., & Aarden, L. A. (1988) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748809098809 · Cited by 137
Serum IL‐1β, IL‐2, and IL‐6 in Insulin‐Dependent Diabetic Children
Doğan, Y., Akarsu, S., Üstündağ, B., et al. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/59206 · Cited by 135
Colitis-associated cancer: the role of T cells in tumor development
Waldner, M. J., & Neurath, M. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0161-8 · Cited by 125
Self-citationActivation of epithelial STAT3 regulates intestinal homeostasis
Neufert, C. F., Pickert, G., Zheng, Y., Wittkopf, N., Warntjen, M., Nikolae, A., Ouyang, W., Neurath, M. F., & Becker, C. (2010) · Cell Cycle · doi:10.4161/cc.9.4.10615 · Cited by 117
Self-citationRose‐John, S., & Neurath, M. F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00003-2 · Cited by 115
Self-citationThe transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis
Weigmann, B., Lehr, H. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. G., Schmidt, J., Galle, P. R., Rose‐John, S., & Neurath, M. F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072484 · Cited by 114
Self-citationEndogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation
Wang, J., Homer, R., Chen, Q., & Elias, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4051 · Cited by 113
Richards, P. J., Nowell, M. A., Horiuchi, S., McLoughlin, R. M., Fielding, C. A., Grau, S., Yamamoto, N., Ehrmann, M., Rose‐John, S., Williams, A. S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21818 · Cited by 113
Colon cancer and the immune system: The role of tumor invading T cells
Waldner, M. J., Schimanski, C.-C., & Neurath, M.-F. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i45.7233 · Cited by 111
Self-citationWhetzel, A. M., Bolick, D. T., Srinivasan, S. R., Macdonald, T. L., Morris, M. A., Ley, K. F., & Hedrick, C. C. (2006) · Circulation Research · doi:10.1161/01.res.0000244088.33375.52 · Cited by 110
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn??s disease
Louis, E. J., Bélaïche, J., Kemseke, C. V., Franchimont, D. P., Groote, D. D., Gueenen, V., & Mary, J. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199710000-00004 · Cited by 101
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 100
TGF-beta as a T cell regulator in colitis and colon cancer
Becker, C., Fantini, M. C., & Neurath, M. F. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.004 · Cited by 98
Self-citationGürr, W., Yavari, R., Li, W., Shaw, M., Mora, C., Christa, L., & Sherwin, R. S. (2002) · Diabetes · doi:10.2337/diabetes.51.2.339 · Cited by 96
Campbell, I. L., Hobbs, M. V., Dockter, J., Oldstone, M. B. A., & Allison, J. (1994) · PubMed · Cited by 95
Hohki, S., Ohguro, N., Haruta, H., Nakai, K., Terabe, F., Serada, S., Fujimoto, M., Nomura, S., Kawahata, H., Kishimoto, T., et al. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.04.009 · Cited by 91
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Linker, R. A., Lühder, F., Kallen, K., Lee, D.-H., Engelhardt, B., Rose‐John, S., & Gold, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.007 · Cited by 84
Yue, C., You, X., Zhao, L., Wang, H., Tang, F.-L., Zhang, F., Zhang, X., & He, W. (2009) · Rheumatology International · doi:10.1007/s00296-009-1179-x · Cited by 83
Britton, K. E. (1996) · Acta Oncologica · doi:10.3109/02841869609101656 · Cited by 81
Sputum IL-6 concentrations in severe asthma and its relationship with FEV1
Morjaria, J., Babu, K. S., Vijayanand, P., Chauhan, A., Davies, D. E., & Holgate, S. T. (2010) · Thorax · doi:10.1136/thx.2010.136523 · Cited by 77
Noguchi, D., Wakita, D., Tajima, M., Ashino, S., Iwakura, Y., Zhang, Y., Chamoto, K., Kitamura, H., & Nishimura, T. (2007) · International Immunology · doi:10.1093/intimm/dxm114 · Cited by 76
Lissilaa, R., Buatois, V., Magistrelli, G., Williams, A. S., Jones, G. W., Herren, S., Shang, L., Malinge, P., Guilhot, F., Chatel, L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002015 · Cited by 69
Andriankaja, O. M., Barros, S. P., MOSS, K. L., Panagakos, F. S., DeVizio, W., Beck, J. D., & Offenbacher, S. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080385 · Cited by 66
Holtkamp, W., Stollberg, T., & Reis, H. E. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199503000-00010 · Cited by 65
Finotto, S., Eigenbrod, T., Karwot, R., Boross, I., Doganci, A., Ito, H., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Rose‐John, S., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm037 · Cited by 65
Self-citationBrown, K. A., Back, S. J., Ruchelli, E. D., Markowitz, J. E., Mascarenhas, M. R., Verma, R., Piccoli, D. A., & Baldassano, R. N. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06030.x · Cited by 59
Kai, Y., Takahashi, I., Ishikawa, H., Hiroi, T., Mizushima, T., Matsuda, C., Kishi, D., Hamada, H., Tamagawa, H., Ito, T., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.013 · Cited by 59
Vladić, A., Horvat, G., Vukadin, S., Sučić, Z., & Šimaga, Š. (2002) · Cytokine · doi:10.1006/cyto.2002.1984 · Cited by 56
Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis.
Umehara, Y., Kudo, M., Nakaoka, R., Kawasaki, T., & Shiomi, M. (2006) · PubMed · Cited by 56
Wu, W., Wang, M., Sun, Z., Wang, X., Miao, J., & Zheng, Z. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0198-0 · Cited by 54
NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammation
Bouma, G., Nikolić, T., Coppens, J. M. C., van Helden-Meeuwsen, C. G., Leenen, P. J. M., Drexhage, H. A., Sozzani, S., & Versnel, M. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425513 · Cited by 49
Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
Liang, B., Song, Z., Wu, B., Gardner, D. B., Shealy, D. J., Song, X.-Y., & Wooley, P. H. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-10 · Cited by 44
Uncoupling of Airway Inflammation and Bronchial Hyperreactivity
DiCosmo, B., Geba, G. P., Picarella, D., Elias, J. A., Rankin, J. A., Stripp, B. R., Whitsett, J. A., & Flavell, R. A. (1994) · Cited by 42
Demonstration of a TH1cytokine profile in the late phase of NOD insulitis
Pilström, B., Björk, L., & Böhme, J. (1995) · Cytokine · doi:10.1006/cyto.1995.0097 · Cited by 40
Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes
Galassetti, P. R., Iwanaga, K., Pontello, A. M., Zaldivar, F. P., Flores, R. L., & Larson, J. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00445.2005 · Cited by 38
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Neurath, M. F., & Finotto, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.016 · Cited by 36
Self-citationYoshida, H., Hashizume, M., Suzuki, M., & Mihara, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.026 · Cited by 35
Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis
Kitamura, K., Nakamoto, Y., Kaneko, S., & Mukaida, N. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0604328 · Cited by 35
Lower Airway Disease in Asthmatics with and without Rhinitis
Dixon, A. E., Raymond, D. M., Suratt, B. T., Bourassa, L. M., & Irvin, C. G. (2008) · Lung · doi:10.1007/s00408-008-9119-1 · Cited by 34
Hausding, M., Tepe, M., Übel, C., Lehr, H. A., Röhrig, B., Höhn, Y., Pautz, A., Eigenbrod, T., Anke, T., Kleinert, H., et al. (2010) · International Immunology · doi:10.1093/intimm/dxq451 · Cited by 33
Self-citationEugster, H., Frei, K., Winkler, F., Koedel, U., Pfister, W., Lassmann, H., & Fontana, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2302::aid-immu2302>3.0.co;2-# · Cited by 26
Ansari, M. A., Dhar, M., Spieker, S., Bakht, N., Rahman, A. M., Moore, W. V., & Jacobson, J. D. (2003) · Endocrinology · doi:10.1210/en.2003-0512 · Cited by 22
Teros, T., Hakala, R., Ylinen, L. M. J., Liukas, A., Arvilommi, P., Sainio-Pöllänen, S., nkorva, E. V. J., nen, P. P. L., & Simell, O. (2000) · Pancreas · doi:10.1097/00006676-200003000-00013 · Cited by 13
The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2
Cited by
Kaptoge, S., Seshasai, S. R. K., Gao, P., Freitag, D. F., Butterworth, A. S., Borglykke, A., Di Angelantonio, E., Gudnason, V., Rumley, A., Lowe, G. D. O., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht367 · Cited by 666
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
COVID-19 infection: an overview on cytokine storm and related interventions
Montazersaheb, S., Hosseiniyan Khatibi, S. M., Hejazi, M. S., Tarhriz, V., Farjami, A., Ghasemian Sorbeni, F., Farahzadi, R., & Ghasemnejad, T. (2022) · Virology Journal · doi:10.1186/s12985-022-01814-1 · Cited by 610
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Metadata
- Authors
- Neurath, M. F., & Finotto, S.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 22
- Issue
- 2
- Pages
- 83-89
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W1996032049
- Cited by
- 576
- References
- 109
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.